36th General Annual Meeting of the BHS 2021
Jane Apperley (Hammersmith Hospital Imperial College London, United Kingdom)

Jane Apperley qualified in Medicine from the University of Birmingham in 1979 and completed specialist training in haematology in Birmingham, London and Cambridge. Throughout this time she developed an interest in stem cell transplantation (SCT), and by default in chronic myeloid leukaemia (CML), which was the primary indication for SCT in the 1990s. She spent two years as a post-doctoral fellow at the Children’s Hospital in Boston, USA, training in gene transfer and therapy. She returned to the Hammersmith Hospital in 1993, was given a personal chair in Haemato-Oncology in 2002, and became the Clinical Director for Clinical Haematology at the Imperial College Healthcare NHS Trust, and the Chair of the Centre of Haematology at the Imperial College in 2003/4. Her interests remain the biology and management of CML, and her group at the Imperial College has extensive experience in the use of first, second and third generation tyrosine kinase inhibitors, particularly in the areas of molecular monitoring, mechanisms of drug resistance and adverse events. She has a long-standing interest in the impact of haematological diseases and their treatment on fertility, pregnancy and foetal outcome. She has been a member of the ELN CML Working Party since the creation of the ELN in 2004 and has been involved with the ELN Consensus Guidelines since the first recommendations in 2006, initially as the ‘expert’ in SCT. She has also been a member of the UK NCRI CML study group for >20 years. Some years ago this group recognised that there were issues in the management of CML peculiar to the UK because of the influence of NICE and the need for financial restraint, and under the leadership of Graeme Smith (Leeds) developed the current BCSH guidelines.

Cristina Baiana (CHU UCL Namur-Mont Godinne, Belgium)

I have been working in the hematology department of the CHU UCL Namur-site Mont-Godinne since 1988. Since 2017, I have held the position of care coordinator in hematology and I am in charge of transplant coordination.

I have been a member of the BHS nursing care group since its creation in 2011. I have been president of the group since 2020. I am also the BHS representative to the French-speaking chamber of the General Union of Nurses of Belgium (UGIB).

Barbara De Moerloose (UGent, Belgium)

I am a pediatrician and pediatric hematologist-oncologist working in the Ghent University Hospital, and associate lecturer at the Ghent University, with specific expertise in leukemia, myelodysplasia and bone marrow failure. I’m an active member of international collaborative groups in these fields of expertise (such as I-BFM, EORTC-Children’s Leukemia Group, NOPHO DBH-AML consortium, EWOG-MDS etc), and Belgian principal investigator of several academic multicenter trials and early phase studies including cellular therapy in pediatric leukemia.

Johan De Munter (UZ Gent, Belgium)

Johan De Munter graduated as a nurse in 2001 and worked for several years on an oncology and haematology ward. In 2006 he moved to a private hospital that wanted to focus on a completely new role in cancer nursing in Belgium. In 2010 he transferred to the University Hospital Ghent, where he continues to work as a nurse consultant in the haematology/stem cell transplant unit. Some time ago he continued his career pathway as an assistant nurse manager of the cancer centre at the university hospital. His professional interests include patient & nurse education, supportive care needs, survivorship & palliative care, and Adolescent and Young Adults (AYA) cancer care. He is involved in the Flemish Society for Radiology and Oncology Nurses, a position in the Belgian Haematology Society’s nurses committee, and has is member of the SIOPE (European Society for Paediatric Oncology) AYA Committee . He is a board member of the Majin home in Ghent, which supports people with cancer and their loved ones. Over a decade he was member EONS (European Oncology Nursing Society) advocacy wg, was chair of EONS communication WG and is currently EONS president elect.

Martine Heylens (UZ Leuven, Belgium)

Martine Heylens is a hematopoietic stem cell transplant nurse in the Haematology Department at the Academic Hospital ‘UZ’- Leuven, with specific expertise and interest in CAR-T cells. She is the co-founder of the BHS Nurses Committee, of witch she is the current vice-president after 5 years of presiding. She periodically joins the Advice Board on Car-T cells.

Starting as a baccalaureate nurse in 1983, she (post)graduated in Emergencies and Intensive Care in 1990 as well as obtained the title of Oncology nurse.
With over 35 years of experience, she is the current First Point of Contact for emergency care and procedures at UZ Hematology Department Isolation Unit.

Jan Loos (UZ Leuven, Belgium)

Jan Loos volgde zijn studies tot arts aan de Katholieke Universiteit van Leuven en studeerde af in 2014. Hij vervolledigt op dit moment zijn opleiding tot Hematoloog aan het UZ Leuven. Hij heeft een bijzondere interesse in infectieziekten en schreef, samen met een panel experten, de richtlijnen voor vaccinatie bij patiënten met hematologische aandoeningen in 2020.

Toine Mercier (UZ Leuven, Belgium)

Toine Mercier graduated as a physician from the faculty of medicine at Leuven University, Belgium, in 2014. In 2020, he successfully defended his PhD thesis on rapid diagnostic methods for invasive fungal infections in hematology patients. Currently, he is in his final years as a resident in hematology at the University Hospitals Leuven, and combines his clinical training with ongoing post-doctoral research on opportunistic respiratory infections. He is an active member of several international infectious disease and hematology societies, and is the secretary of the Belgian Society of Human and Animal Mycology. He has been recognized as a Fellow of the Academy of the European Confederation of Medical Mycology for his work in research and education. His main interests are in supportive care, invasive fungal infections, diagnostic tools, bioinformatics and data science.

Eva Oldenburger (UZ Leuven, Belgium)

Dr. Eva Oldenburger, M.D., works as a Radiation Oncologist and a Palliative Care Physician in the University Hospitals of Leuven. As a Radiation Oncologist she focusses on the treatment of patients with breast cancer, both curative and palliative, as well as palliative patients. As a Palliative Care physician she primarily works on the palliative ward where there are 12 beds. Dr. Oldenburger is currently completing her Ph.D. on Patient Reported Outcome Measures for patients treated with palliative radiotherapy and its effect on symptoms and Quality of Life. After her Ph.D. she hopes to integrate Patient Reported Outcomes and patient-centered symptom management in standard care in her hospital.

Marijke Quaghebeur (UZ Gent, Belgium)

Clinical nurse specialist haematology for 10 years at the University Hospital Gent. Twenty years ‘ experience in haematology and stem cell transplantation. She is involved in patient education and follow-up. She works together with different stakeholders (patient and nurses organizations, nursing schools…). Guest lecturer in haematology nursing topics, immunocompromised patient and care for Adolesents and Young Adults (AYA) with cancer. Board member of the nursing group in the BHS and Care 4AYA vzw. Member of the EBMT nursing group scientific committee.

Anne Sonet (CHU UCL Namur-Mont Godinne, Belgium)

Professor Anne Sonet is a clinical haematologist since 1995. She is responsible of the haematology hospitalisation unit at the Cliniques Universitaires de Mont-Godinne. By her position, she is particularly involved in supportive care of critical haematological situations.


Jo Storms (Jessa Ziekenhuis Hasselt, Belgium)

I am Jo Storms and I work at the Jessa Hospital for 30 years. My first four years I worked at the cardiovascular department as a nurse. Since 1995 I work at the hematology department as a nurse with direct patiënt care and also as a coördinator at the hematology ward. I also worked part time as a prostate nurse from 2009 until 2018. Since 2009 I am a part time datamanager for the EBMT (European Society for Blood and Marrow Transplantation).

Ann Tegethoff (AZ Sint-Jan Brugge, Belgium)

I am a nurse specialist in hematology with a special affinity for stem cell transplantation and donor follow-up within the AZ Sint-Jan hospital in Bruges. For more than six years, I have been involved in the field of the hematology patient. In addition to my job as nurse, it is a passion of mine to provide the necessary training/ education to others. I have been a board member of the BHS nurses group since 2015, while being secretary for the last three years.

Gaëlle Vanbutsele (UGent, Belgium)

Gaëlle Vanbutsele (°1985) is coordinator of the Patient Centred Cancer Care Research Group and postdoctoral assistant at the Faculty of Medicine and Health Sciences of Ghent University. She has a master’s degree in clinical psychology and a PhD degree in (Social) Health Sciences (2018). Her research has been awarded with different prizes and been published in high ranking journals including the Lancet Oncology.

Her main focus of interest is in practice-based research to improve supportive care for patients with cancer and their families.
She is experienced in conducting and analysing various methodologies: qualitative interviews/focus groups, population-based studies and randomized controlled trials and implementation.
She is coordinating different projects related to information provision and psychosocial support for patients with hematologic and solid cancers.

Erika Vlieghe (UZ Antwerpen, Belgium)

Erika Vlieghe has graduated at KU Leuven in 1996. In 1997 she did a postgraduate at the Institute of Tropical Medicine in Antwerp. Accordingly she worked two years in Oeganda. From 1999-2004 she specialized in general internal medicine. Afterwards she teached at KU Leuven regarding antibiotic resistance in Cambodia.

Currently she is head of the department of General Internal Medicine, Infectious Diseases and Tropical Medicine at University Hospital Antwerp. She has a leading role in the Belgian crisis management for Ebola and COVID-19.